New biocompatible polymer surface coating for stents results in a low neointimal response

Journal of Biomedical Materials Research

Volumn 52, Issue 1, 2000, Pages 193-198

  Bär, Frits W ^a   Van Der Veen, Frederik H ^b   Benzina, Abder ^c   Habets, Jo ^b   Koole, Leo H ^c  

^a MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^b MAASTRICHT UNIVERSITY   (Netherlands)

^c MAASTRICHT UNIVERSITY   (Netherlands)

Author keywords

Coating; Hyperplasia; MMA HEMA; Polymer; Stent

Indexed keywords

BIOCOMPATIBILITY; BLOOD VESSELS; COATINGS; IMPLANTS (SURGICAL); NUMERICAL ANALYSIS; STATISTICAL METHODS; TRANSPLANTATION (SURGICAL);

CORONARY ARTERIES; HYPERPLASIA; NEOINTIMAL RESPONSE; STENTS;

POLYMETHYL METHACRYLATES;

ANIMAL TISSUE; ARTICLE; BIOCOMPATIBILITY; BLOOD VESSEL INJURY; CONTROLLED STUDY; CORONARY STENT; HYPERPLASIA; INTIMA; NONHUMAN; SWINE; TISSUE REACTION;

EID: 0343517467     PISSN: 00219304     EISSN: None     Source Type: Journal    
DOI: 10.1002/1097-4636(200010)52:1<193::AID-JBM25>3.0.CO;2-7     Document Type: Article

References (24)

1. Sigward U, Puel J, Mirkovitch V, et al. Intravascular stents to prevent occlusion and restenosis after transluminal angioplasty. N Engl J Med 1987;316:701-706.
2. Thomas MR, Wainwright J, Hancock J, et al. Coronary stenting following successful angioplasty for total occlusions: Preliminary results of a randomized trial. J Intervent Cardiol 1996;8: 107(A).
3. Schatz RA. A view of vascular stents. Circulation 1989;79:445-457.
4. Serruys PW, De Jaegere P, Kiemeneij F, et al. A comparison of balloon-expandable-stent implantation with balloon angioplasty in patients with coronary artery disease: Benestent Study group. N Engl J Med 1994;331:489-495.
5. Fischman DL, Leon MB, Baim DS, et al. A randomized comparison of coronary stent placement and balloon angioplasty in the treatment of coronary artery disease: Stent Restenosis Study Investigators. N Engl J Med 1994;331:496-501.
6. Serruys PW, Emanuelsson H, Van der Giessen W, et al. Heparin-coated Palmaz-Schatz stents in human coronary arteries: Early outcome of the Benestent - II. Pilot study. Circulation 1996;93:412-422.
7. Macaya C, Serruys PW, Ruygrok P, et al. Continued benefit of coronary stenting versus balloon angioplasty: One year clinical follow-up on Benestent trial: Benestent Study Group. J Am Coll Cardiol 1996;27:255-261.
8. Kruft MAB, Van der Veen FH, Koole LH. In vivo tissue compatibility of two radio-opaque polymeric biomaterials. Biomaterials 1997;18:31-36.
9. Kruft MAB, Benzina A, Blezer R, Koole LH. Studies on radioopaque polymeric biomaterials with potential applications to endovascular prostheses. Biomaterials 1996;17:1803-1812.
10. Waale WHE, Van der Veen FH, Van Leeuwen C, et al. Modulation of healthy pig coronary arteries by self-expanding stents. J Intervent Cardiol 1996;9:45-52.
11. Schwartz RS, Huber KC, Murphy JG, et al. Restenosis and the proportional neointimal response to coronary artery injury: Results in a porcine model. J Am Coll Cardiol 1992;19:267-274.
12. Bär FWHM, Van Oppen J, De Swart H, et al. Percutaneous implantation of a new intracoronary stent in pigs. Am Heart J 1991;122:1532-1541.
13. Van der Giessen WJ, Lincoff AM, Schwartz RS, et al. Marked inflammatory sequelae to implantation of biodegradable and nonbiodegradable polymers in porcine coronary arteries. Circulation 1996;94:1690-1697.
14. Lindhout T, Blezer R, Maassen C, Heijen V, Reutelingsperger CPM. Platelet procoagulant surface as an essential parameter for the in-vitro evaluation of the blood compatibility of polymers. J Mater Sci Mater Med 1995;6:367-372.
15. Hemker HC, Willems GM, Géguin SA. A computer assisted method to obtain the prothrombin activation velocity in whole plasma independent of thrombin decay processes. Thromb Haemost 1986;56:9-17.
16. Okano T, Nishiyama S, Shinohara I, et al. Effect of hydrophilic and hydrophobic microdomains on mode of interaction between block polymer and blood platelets. J Biomed Mater Res 1981;15:393-402.
17. Sasaki T, Ratner BD, Hoffman AS. Radiation-induced co-graft polymerization of 2-hydroxyethyl methacrylate and ethyl methacrylate onto silicone rubber films. ACS Symp Ser 1976; 31:283-294.
18. Nyilas E, Morton WA, Lederman DM, Chiu TH, Cumming RD. Interdependence of hemodynamic and surface parameters in thrombosis. Trans Am Artif Intern Organs 1975;21:55-70.
19. Hårdhammar PA, Van Beusekom HMM, Emanuelsson HU, et al. Reduction in thrombotic events with heparin-coated Palmaz-Schatz stents in normal porcine coronary arteries. Circulation 1996;93:423-430.
20. Van der Giessen WJ, Van Beusekom HMM, Van Houten CD, Van Woerkens LJ, Verdouw PD, Serruys PW. Coronary stenting with polymer-coated and uncoated self-expanding endoprostheses in pigs. Coron Artery Dis 1992;3:631-640.
21. Schatz R, Baim DS, Leon M, et al. Clinical experience with the Palmaz-Schatz coronary stent: Initial results of a multicenter study. Circulation 1991;83:148-161.
22. Keszler B, Kennedy JP, Mackey PW. Amphiphilic networks. VI. Swelling and sustained release of poly (N,N-dimethylacrylamide)-1-polyisobutylene, poly (N,N-dimethylamino ethylmethacrylate)-1-polyisobutylene and poly (2-hydroxyethyl methacrylate)-1-polyisobutylene networks. J Control Rel 1993;25:115-121.
23. Muller DWM, Topol EJ. Implantable devices in the coronary artery from metal to genes. Trends Cardiovasc Med 1991;1: 225-232.
24. Wilensky RL, March KL, Gradus-Pizlo I, Speady AJ, Hathaway D. Methods and devices for local drug delivery in coronary and peripheral arteries. Trends Cardiovasc Med 1993;3:163-170.